Retraction: Hyaluronic Acid and Thrombin Upregulate MT1-MMP Through PI3K and Rac-1 Signaling and Prime the Homing-Related Responses of Cord Blood Hematopoietic Stem/Progenitor Cells (Stem Cells and Development (2011) 20:1 (19-30) DOI: 10.1089/scd.2010.0118);Hyaluronic acid and thrombin upregulate MT1-MMP through PI3K and Rac-1 signaling and prime the homing-related responses of cord blood hematopoietic stem/progenitor cells

Stem Cells and Development

Volumn 20, Issue 1, 2011, Pages 19-30

  Shirvaikar, Neeta ^a,b   Marquez Curtis, Leah A ^a   Ratajczak, Mariusz Z ^c   Janowska Wieczorek, Anna ^a,b  

^a CANADIAN BLOOD SERVICES   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 AMINO 6 [2 [[4 (DIETHYLAMINO) 1 METHYLBUTYL]AMINO] 6 METHYL 4 PYRIMIDINYL] 2 METHYLQUINOLINE; CD34 ANTIGEN; GELATINASE A; HYALURONIC ACID; MATRIGEL; MATRIX METALLOPROTEINASE 14; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; RAC1 PROTEIN; STROMAL CELL DERIVED FACTOR 1; THROMBIN;

ARTICLE; BASEMENT MEMBRANE; CELL HOMING; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKAPHERESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SUPERNATANT; UMBILICAL CORD BLOOD; UPREGULATION;

EID: 78650971739     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0118.retract     Document Type: Erratum

References (41)

1. Laughlin MJ, M Eapen, P Rubinstein, JE Wagner, MJ Zhang, RE Champlin, C Stevens, JN Barker, RP Gale, HM Lazarus, DI Marks, JJ van Rood, A Scaradavou and MM Horowitz. (2004). Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Eng J Med 351:2265-2275.
2. Tse W, KD Bunting and MJ Laughlin. (2008). New insights into cord blood stem cell transplantation. Curr Opin Hematol 15:279-284.
3. Papayannopoulou T and DT Scadden. (2008). Stem-cell ecology and stem cells in motion. Blood 111:3923-3930.
4. Lapidot T, A Dar and O Kollet. (2005). How do stem cells find their way home? Blood 106:1901-1910.
5. Chute JP. Stem cell homing. (2006). Curr Opin Hematol 13:399-405.
6. Peled A, O Kollet, T Ponomaryov, I Petit, S Franitza, V Grabovsky, MM Slav, A Nagler, O Lider, R Alon, D Zipori and T Lapidot. (2000). The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34 cells: role in transendothelial=stromal migration and engraftment of NOD=SCID mice. Blood 95:3289-3296.
7. Papayannopoulou T. (2006). Hierarchy of molecularpathway usage in bone marrow homing and its shift by cytokines. Blood 107:79-86.
8. Janowska-Wieczorek A, LA Marquez, J-M Nabholtz, ML Cabuhat, J Montaño, H Chang, J Rozmus, JA Russell, DR Edwards and AR Turner. (1999). Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34 cells and their transmigration through reconstituted basement membrane. Blood 93:3379-3390.
9. Janowska-Wieczorek A, LA Marquez, A Dobrowsky, MZ Ratajczak and ML Cabuhat. (2000). Differential MMP and TIMP production by human marrow and peripheral blood CD34 cells in response to chemokines. Exp Hematol 28:1274-1285.
10. Elfenbien GJ and R Sackstein. (2004). Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow. Exp Hematol 32:327-339.
11. Wysoczynski M, R Reca, J Ratajczak, M Kucia, N Shirvaikar, M Honczarenko, M Mills, J Wanzeck, A Janowska-Wieczorek and MZ Ratajczak. (2005). Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem=progenitor cells to an SDF-1 gradient. Blood 105:40-48.
12. Avigdor A, P Goichberg, S Shivtiel, A Dar, A Peled, S Samira, O Kollet, R Hershkoviz, R Alon, I Hardan, H Ben-Hur, D Naor, A Nagler and T Lapidot. (2004). CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34 stem=progenitor cells to bone marrow. Blood 103:2981-2989.
13. Lane DA, H Phillipou and JA Huntington. (2005). Directing thrombin. Blood 106:2605-2612.
14. Murphy G and H Nagase. (2008). Progress in matrix metalloproteinase research. Mol Aspects Med 29:290-308.
15. Butler GS and CM Overall. (2009). Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics. Biochemistry 48:10830-10845.
16. Roy R, J Yang and MA Moses. (2009). Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 27:5287-5297.
17. Nagase H, R Visse and G Murphy. (2006). Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69:562-573.
18. Rodríguez D, CJ Morrison and CM Overall. (2009). Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. Biochim Biophys Acta 1803:39-54.
19. Itoh Y and M Seiki. (2006). MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol 206:1-8.
20. Kajita M, Y Itoh, T Chiba, H Mori, A Okada, H Kinoh and M Seiki. (2001).Membrane-type 1matrixmetalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 153:893-904.
21. Robinet A, A Fahem, JH Cauchard, E Huet, L Vincent, S Lorimier, F Antonicelli, C Soria, M Crepin, W Hornebeck and G Bellon. (2005). Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP. J Cell Sci 118:343-356.
22. Matias-Roman S, BG Galvez, L Genis, M Yáñez-Mó, G de la Rosa, P Sánchez-Mateos, F Sánchez-Madrid and AG Arroyo. (2005). Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium. Blood 105:3956-3964.
23. Son B, LA Marquez-Curtis, M Kucia, M Wysoczynski, AR Turner, J Ratajczak, MZ Ratajczak and A Janowska-Wieczorek. (2006). Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal cell-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 24:1254-1264.
24. Shirvaikar N, R Reca, A Jalili, LA Marquez-Curtis, SF Lee, MZ Ratajczak and A Janowska-Wieczorek. (2008). CFU-Meg progenitors ex vivo-expanded from cord blood maintain their in vitro homing potential and express matrix metalloproteinases. Cytotherapy 10:182-192.
25. Vagima Y, A Avigdor, P Goichberg, S Shivtiel, M Tesio, A Kalinkovich, K Golan, A Dar, O Kollet, I Petit, O Perl, E Rosenthal, I Resnick, I Hardan, YN Gellman, D Naor, A Nagler and T Lapidot. (2009). MT1-MMP and RECK are involved in human CD34 progenitor cell retention, egress, and mobilization. J Clin Invest 119:492-503.
26. Ridley AJ, MA Schwartz, K Burridge, RA Firtel, MH Ginsberg, G Borisy, JT Parsons and AR Horwitz. (2003). Cell migration integrating signals from front to back. Science 302:1704-1709.
27. Kolsch V, PG Charest and RA Firtel. (2008). The regulation of cell motility and chemotaxis by phospholipids signalling. J Cell Sci 121:551-559.
28. Fuhler GM, AL Drayer, SGM Olthof, JJ Schuringa, PJ Coffer and E Vellenga. (2008). Reduced activation of protein kinase B, Rac, and F-actin contributes to an impairment of stromal cell-derived factor-1-induced migration of CD34 cells from patients with myelodysplasia. Blood 111:359-368.
29. Etienne-Manneville S and A Hall. (2002). Rho GTPases in cell biology. Nature 420:629-635.
30. Murai T, Y Miyazaki, H Nishinakamura, KN Sugahara, T Miyauchi, Y Sako, T Yanagida and M Miyasaka. (2004). Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor metastasis. J Biol Chem 279:4541-4550.
31. Azim AC, K Barkalow, J Chou and JH Hartwig. (2000). Activation of the small GTPases, rac and cdc42, after ligation of the platelet PAR-1 receptor. Blood 95:959-964.
32. Gu Yi, M-D Filippi, JA Cancelas, JE Siefring, EP Williams, AC Jasti, CE Harris, AW Lee, R Prabhakar, SJ Atkinson, DJ Kwiatkowski and DA Williams. (2003). Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. Science 302:445-449.
33. Cancelas JA, AW Lee, R Prabhakar, KF Stringer, Y Zheng Y and DA Williams. (2005). Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization. Nat Med 11:886-891.
34. Bartolome RA, I Molina-Ortiz, R Samaniego, P Sánchez-Mateos, XR Bustelo and J Teixidó. (2006). Activation of Vav=Rho GTPase signaling by CXCL12 controls membranetype matrix metalloproteinase-dependent melanoma cell invasion. Cancer Res 66:248-258.
35. Shirvaikar N, LA Marquez-Curtis, AR Shaw, AR Turner and A Janowska-Wieczorek. (2010). MT1-MMP association with membrane lipid rafts facilitates G-CSF-induced hematopoietic stem=progenitor cell mobilization. Exp Hematol 38: 823-835.
36. Zhang D and P Brodt. (2003). Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI3-kinase=AKT signaling. Oncogene 22:974-982.
37. Ispanovic E and TL Haas. (2006). JNK and PI3K differentially regulate MMP-2 and MT1-MMP mRNA and protein in response to cytoskeleton reorganization in endothelial cells. Am J Physiol Cell Physiol 291:C579-C588.
38. Zhuge Y and J Xu. (2001). Rac1 mediates type I collagendependent MMP-2 activation. Role in cell invasion across collagen barrier. J Biol Chem 276:16248-16256.
39. Itoh Y, A Takamura, N Ito, Y Maru, H Sato, N Suenaga, T Aoki and M Seiki. (2001). Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J 20: 4782-4793.
40. Barber MA and HCE Welch. (2006). PI3K and RAC signalling in leukocyte and cancer cell migration. Bull Cancer 93:E44-E52.
41. Charest PG and RA Firtel. (2006). Feedback signalling controls leading-edge formation during chemotaxis. Curr Opin Genet Dev 16:339-347.